Using the anglerfish model, Habeners team identified a precursor to glucagon capable of also encoding a new and much sought after hormone: the glucagon-like peptide 1, better known as GLP-1
Highlights of Prescribing Information: BYETTA (exenatide) injection, for subcutaneous use
Triple-hormone-receptor agonist retatrutide for obesity: A phase 2 trial. New England Journal of Medicine
[DOI] [PubMed] [Google Scholar] 17.Ryan D.H., Lingvay I., Deanfield J., Kahn S.E., Barros E., Burguera B., Colhoun H.M., Cercato C., Dicker D., Horn D.B., et al
A note on why the concentration choice matters beyond convenience: a higher-concentration build (10 mg/mL) keeps every draw comfortably inside one barrel across the whole ladder, but leaves less margin for a small measurement slip, since each unit carries more drug